Table of Content

1. US - Rheumatoid Arthritis Drugs Market Overview
1.1 Current Market Scenario
1.2 Rheumatoid Arthritis Prevalence & Statistics
1.3 US Rheumatoid Arthritis Drugs Clinical Trials Insight


2. US: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for Rheumatoid Arthritis – Branded & Generic Availability, Dosage, Patent & Price Analysis
2.1 Meloxicam (Mobic)
2.2 Ketoprofen
2.3 Diflunisal
2.4 Fenoprofen
2.5 Flurbiprofen
2.6 Meclofenamate
2.7 Tolmetin
2.8 Etodolac
2.9 Nabumetone (Relafen)
2.10 Indomethacin
2.11 Oxaprozin
2.12 Piroxicam
2.13 Sulindac
2.14 Diclofenac / Misoprostol
2.15 Esomeprazole / Naproxen
2.16 Famotidine / Ibuprofen
2.17 Diclofenac
2.18 Naproxen
2.19 Ibuprofen


3. US: Salisylates Drugs for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis
3.1 Aspirin
3.2 Salsalate
3.3 Sulfasalazine (Azulfidine)


4. US: Tetracyclines for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis
4.1 Doxycycline
4.2 Minocycline
4.3 Tetracycline


5. US: Narcotic Analgesic Drugs for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis
5.1 Acetaminophen / Hydrocodone
5.2 Acetaminophen / Tramadol


6. US: Topical Rubifacient for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis
6.1 Methyl Salicylate
6.2 Camphor / Menthol / Methyl Salicylate
6.3 Trolamine Salicylate


7. US: Antimetabolites for Rheumatoid Arthritis - Branded & Generic Availability,
Dosage & Price Analysis
7.1 Methotrexate


8. US: Glucocorticoides Drugs for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis
8.1 Prednisone
8.2 Methylprednisolone
8.3 Triamcinolone (Kenalog-40)
8.4 Dexamethasone
8.5 Cortisone


9. US: Quinolines for Rheumatoid Arthritis - Branded & Generic Availability, Dosage & Price Analysis
9.1 Hydroxychloroquine


10. US: Disease-Modifying Antirheumatic Drugs (DMARDs) – Branded & Generic Availability, Dosage, Patent & Price Analysis
10.1 Leflunomide


11. US: TNF Inhibitors - Branded & Generic Availability, Dosage, Patent, Price & Sales Analysis
11.1 Etanercept
11.2 Abatacept


12. US: Monoclonal Antibody - Branded & Biosimilars Availability, Dosage, Patent, Price & Sales Analysis
12.1 Adalimumab
12.2 Tocilizumab
12.3 Infliximab
12.4 Rituximab
12.5 Certolizumab
12.6 Golimumab
12.7 Alemtuzumab
12.8 Sarilumab
12.9 Canakinumab



13. US: Statin - Branded & Generic Availability, Dosage, Patent & Price Analysis
13.1 Atorvastatin


14. US: Immunosuppresants - Branded & Generic Availability, Dosage, Patent & Price Analysis
14.1 Azathioprine
14.2 Anakinra
14.3 Mycophenolate Mofetil


15. US: JAK Inhibitors for Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Price & Sales Analysis
15.1 Tofacitinib (Xeljanz)
15.2 Upadacitinib (Rinvoq)
15.3 Baricitinib (Olumiant)


16. Other Drugs Targeting Rheumatoid Arthritis - Branded & Generic Availability, Dosage, Patent & Price Analysis
16.1 Cyclophosphamide
16.2 Cyclosporine
16.3 Corticotropin
16.4 Penicillamine
16.5 Interferon Gamma-1b (Actimmune)
16.6 Phenytoin


17. Competitive Landscape
17.1 AbbVie
17.2 Bayer
17.3 Bristol Myers Squibb
17.4 Eli Lilly & Company
17.5 Genentech
17.6 Janssen Pharmaceuticals
17.7 Novartis
17.8 Pfizer
17.9 Roche
17.10 Sanofi
17.11 Sun Pharma
17.12 Teva Pharmaceuticals